4//SEC Filing
CRAIG WILLIAM S 4
Accession 0001209191-09-057973
CIK 0001333248other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 5:58 PM ET
Size
12.7 KB
Accession
0001209191-09-057973
Insider Transaction Report
Form 4
Transactions
- Sale
Common stock
2009-12-17$10.00/sh−10,000$100,000→ 2,000 total - Exercise/Conversion
Common stock
2009-12-17$0.40/sh+5,000$2,000→ 7,000 total - Exercise/Conversion
Stock option (right to buy)
2009-12-17−5,000→ 55,000 totalExercise: $0.40From: 2005-02-16Exp: 2015-02-15→ common stock (5,000 underlying) - Exercise/Conversion
Common stock
2009-12-17$1.36/sh+5,000$6,800→ 12,000 total - Exercise/Conversion
Stock option (right to buy)
2009-12-17−5,000→ 83,825 totalExercise: $1.36From: 2006-05-09Exp: 2016-05-08→ common stock (5,000 underlying)
Footnotes (2)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2009.
- [F2]Not applicable to this transaction.
Documents
Issuer
CADENCE PHARMACEUTICALS INC
CIK 0001333248
Entity typeother
Related Parties
1- filerCIK 0001216988
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 5:58 PM ET
- Size
- 12.7 KB